MedRx Co., Ltd (TYO:4586)
Japan · Delayed Price · Currency is JPY 60.00
0.00 (0.00%)
Oct 6, 2026, 2:36 PM JST
MedRx Financials Overview
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 121 | 128 | 257 | 29 | 59 | 8 |
Revenue Growth | 175.00% | -50.20% | 786.21% | -50.85% | 637.50% | -93.04% |
Gross Profit Gross Profit Growth | 118 | 126 | 257 | 26 | 56 | 6 |
Operating Income Operating Income Growth | -876 | -942 | -793 | -934 | -1,101 | -1,061 |
Net Income Net Income Growth | -859 | -937 | -806 | -932 | -1,111 | -1,059 |
Earnings Per Share EPS Growth | -14.58 | -17.44 | -18.54 | -26.80 | -43.80 | -49.58 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Japan Japan Growth | 96.98 | 103.98 | 0.33 | 29 | 59 | 8 |
United States of America United States of America Growth | - | 24.11 | 257.59 | - | - | - |
Total Total Growth | 121.08 | 128.08 | 257.91 | 29 | 59 | 8 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,143 | 1,754 | 1,977 | 1,720 | 994 | 1,703 |
Total Debt Total Debt Growth | - | - | - | - | - | - |
Net Cash (Debt) Net Cash Growth | 1,143 | 1,754 | 1,977 | 1,720 | 994 | 1,703 |
Net Cash Growth | -31.43% | -11.28% | 14.94% | 73.04% | -41.63% | -3.35% |
Net Cash Per Share Net Cash Per Share Growth | 19.40 | 32.64 | 45.48 | 49.46 | 39.19 | 79.74 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -895 | -888 | -803 | -913 | -1,073 | -923 |
Capital Expenditures CapEx Growth | -85 | -82 | - | - | -1 | -2 |
Free Cash Flow Free Cash Flow Growth | -980 | -970 | -803 | -913 | -1,074 | -925 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 97.52% | 98.44% | 100.00% | 89.66% | 94.92% | 75.00% |
Operating Margin | -723.97% | -735.94% | -308.56% | -3220.69% | -1866.10% | -13262.50% |
Pretax Margin | -699.17% | -722.66% | -312.06% | -3206.90% | -1881.36% | -13225.00% |
Profit Margin | -709.92% | -732.03% | -313.62% | -3213.79% | -1883.05% | -13237.50% |
FCF Margin | -809.92% | -757.81% | -312.45% | -3148.28% | -1820.34% | -11562.50% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | - | 8.82 | 8.82 | 8.82 | 8.82 | 8.82 |
PS Ratio | 33.98 | 50.09 | 15.11 | 199.76 | 45.17 | 393.52 |